TRAUMAGEL Study Highlights Sustained Hemorrhage Control and Tourniquet Removal Without Rebleeding

Data ReadoutpositiveTRAUMAGELPositive

AI Analysis

Summary

Cresilon announced TRAUMAGEL study results demonstrating sustained hemorrhage control and successful tourniquet removal without rebleeding in clinical cases involving gunshot wounds, industrial trauma, and sharp-force injuries during prolonged field care.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Clinical cases demonstrate successful sustained hemorrhage control and tourniquet removal without rebleeding in gunshot wounds, industrial trauma and sharp-force injuries

Importance:5/10

Sentiment:

0.70

hemorrhage controltraumaclinical casestourniquet conversionfield care

Read the original article

Published by PR Newswire Biotech on July 7, 2026 12:20 PM

Read Original